Updated:
Facet Life Sciences
SCIENTIFIC AND REGULATORY EXPERTISE TO GET YOU TO AND THROUGH FDA | Facet Life Sciences is a trusted, award-winning regulatory affairs and product development...
Facet Life Sciences
SCIENTIFIC AND REGULATORY EXPERTISE TO GET YOU TO AND THROUGH FDA | Facet Life Sciences is a trusted, award-winning regulatory affairs and product development consulting firm, purpose-built for small life science companies. Our team brings authentic, science-first expertise to help emerging pharmaceutical, biotechnology, and medical device companies navigate the complex path to and through the US FDA.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
Wayne
Corporate office
Wayne, PA, United States
Additional offices
Portland, OR · Lake Oswego, OR · San Mateo, CA · Bend, OR
Principals
Ken VanLuvanee
CEO and Board Chairman
Lisa Jenkins VanLuvanee, Ph.D.
Chief Values Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Facet Life Sciences?
Ken VanLuvanee serves as CEO and Board Chairman. The firm has not disclosed any separate investment committee or CIO role; its activities appear to focus on regulatory consulting rather than asset management.
Is Facet Life Sciences a family office or a consulting firm?
Facet Life Sciences describes itself as a regulatory strategy and product development partner for small biotech companies. It does not present itself as managing third-party capital or as a family office; its revenue model is fee-for-service, not investment returns.
How does Facet Life Sciences source proprietary deal flow?
Facet does not publicly describe a proprietary sourcing model. Client testimonials on its website suggest that engagement typically begins when a small biotech company requires regulatory guidance for a specific product development program.
Does Facet Life Sciences participate in fund commitments or only direct deals?
Facet Life Sciences reports no fund commitments. Its operations are limited to providing regulatory, medical writing, statistical, and asset valuation services to life science companies.
What investment stages does Facet Life Sciences typically target?
Facet's website outlines support across the full product development lifecycle, from discovery and preclinical research through clinical trials, IND/IDE submissions, marketing applications, and commercial launch. It does not specify a preferred stage for engagement.
Which sectors does Facet Life Sciences explicitly avoid?
Facet does not publish a list of avoided sectors. Its stated therapeutic experience spans all therapeutic areas and most dosage forms, suggesting broad sector coverage within life sciences.
Does Facet Life Sciences maintain philanthropic structures, and how are they separated?
Facet Life Sciences does not disclose any separate philanthropic foundation or charitable vehicle. No such entity is mentioned on its website or in available public records.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: